Molecular epidemiology and antimicrobial resistance of invasive non-typhoidal Salmonella in China, 2007–2016

References

• Kariuki S, Gordon MA, Feasey N, Parry CM. Antimicrobial resistance and management of invasive Salmonella disease. Vaccine. 2015;33(Suppl 3):C21–C29. doi:10.1016/j.vaccine.2015.03.10225912288
   PubMed Web of Science ®Google Scholar
• Ao TT, Feasey NA, Gordon MA, Keddy KH, Angulo FJ, Crump JA. Global burden of invasive nontyphoidal Salmonella disease. Emerg Infect Dis. 2015;21(6). doi:10.3201/eid2101.140256
   Web of Science ®Google Scholar
• Vugia DJ, Samuel M, Farley MM, et al. Invasive Salmonella infections in the United States, FoodNet, 1996-1999: incidence, serotype distribution, and outcome. Clin Infect Dis. 2004;38(Suppl 3):S149–S156. doi:10.1086/38158115095184
   PubMed Web of Science ®Google Scholar
• Deen J, von Seidlein L, Andersen F, Elle N, White NJ, Lubell Y. Community-acquired bacterial bloodstream infections in developing countries in south and southeast Asia: a systematic review. Lancet Infect Dis. 2012;12(6):480–487. doi:10.1016/S1473-3099(12)70028-222632186
   PubMed Web of Science ®Google Scholar
• Reddy EA, Shaw AV, Crump JA. Community-acquired bloodstream infections in Africa: a systematic review and meta-analysis. Lancet Infect Dis. 2010;10(6):417–432. doi:10.1016/S1473-3099(10)70072-420510282
   PubMed Web of Science ®Google Scholar
• Angelo KM, Reynolds J, Karp BE, Hoekstra RM, Scheel CM, Friedman C. Antimicrobial resistance among nontyphoidal salmonella isolated from blood in the United States, 2003–2013. J Infect Dis. 2015;214(10):1565–1570. doi:10.1093/infdis/jiw415
   Web of Science ®Google Scholar
• Gordon MA. Invasive nontyphoidal Salmonella disease: epidemiology, pathogenesis and diagnosis. Curr Opin Infect Dis. 2011;24(5):484–489. doi:10.1097/QCO.0b013e32834a998021844803
   PubMed Web of Science ®Google Scholar
• Zhan Z, Kuang D, Liao M, et al. Antimicrobial susceptibility and molecular typing of salmonella senftenberg isolated from humans and other sources in Shanghai, China, 2005 to 2011. J Food Prot. 2017;80(1):146–150. doi:10.4315/0362-028X.JFP-16-25528221879
   PubMed Web of Science ®Google Scholar
• Muthumbi E, Morpeth SC, Ooko M, et al. Invasive Salmonellosis in Kilifi, Kenya. Clin Infect Dis. 2015;61(Suppl 4):S290–S301. doi:10.1093/cid/civ73726449944
   PubMed Web of Science ®Google Scholar
• Phu Huong Lan N, Le Thi Phuong T, Nguyen Huu H, et al. Invasive non-typhoidal salmonella infections in Asia: clinical observations, disease outcome and dominant serovars from an infectious disease hospital in Vietnam. PLoS Negl Trop Dis. 2016;10(8):e0004857. doi:10.1371/journal.pntd.000444627513951
   PubMed Web of Science ®Google Scholar
• Crump JA, Sjolund-Karlsson M, Gordon MA, Parry CM. Epidemiology, clinical presentation, laboratory diagnosis, antimicrobial resistance, and antimicrobial management of invasive salmonella infections. Clin Microbiol Rev. 2015;28(4):901–937. doi:10.1128/CMR.00002-1526180063
   PubMed Web of Science ®Google Scholar
• Panchalingam S, Antonio M, Hossain A, et al. Diagnostic microbiologic methods in the GEMS-1 case/control study. Clin Infect Dis. 2012;55(Suppl 4):S294–S302. doi:10.1093/cid/cis75423169941
   PubMed Web of Science ®Google Scholar
• Kalonji LM, Post A, Phoba MF, et al. Invasive salmonella infections at multiple surveillance sites in the Democratic Republic of the Congo, 2011-2014. Clin Infect Dis. 2015;61(Suppl 4):S346–S353. doi:10.1093/cid/civ71326449951
   PubMed Web of Science ®Google Scholar
• Jiang HX, Song L, Liu J, et al. Multiple transmissible genes encoding fluoroquinolone and third-generation cephalosporin resistance co-located in non-typhoidal Salmonella isolated from food-producing animals in China. Int J Antimicrob Agents. 2014;43(3):242–247. doi:10.1016/j.ijantimicag.2013.12.00524581597
   PubMed Web of Science ®Google Scholar
• Menezes GA, Harish BN, Khan MA, Goessens WH, Hays JP. Antimicrobial resistance trends in blood culture positive Salmonella Typhi isolates from Pondicherry, India, 2005-2009. Clin Microbiol Infect. 2012;18(3):239–245. doi:10.1111/j.1469-0691.2011.03546.x21714829
   PubMed Web of Science ®Google Scholar
• Qiao J, Zhang Q, Alali WQ, et al. Characterization of extended-spectrum beta-lactamases (ESBLs)-producing Salmonella in retail raw chicken carcasses. Int J Food Microbiol. 2017;248:72–81. doi:10.1016/j.ijfoodmicro.2017.02.01628288398
   PubMed Web of Science ®Google Scholar
• Nguyen DTA, Kanki M, Nguyen PD, et al. Prevalence, antibiotic resistance, and extended-spectrum and AmpC β-lactamase productivity of Salmonella isolates from raw meat and seafood samples in Ho Chi Minh City, Vietnam. Int J Food Microbiol. 2016;236:115–122. doi:10.1016/j.ijfoodmicro.2016.07.01727479779
   PubMed Web of Science ®Google Scholar
• Eguale T, Birungi J, Asrat D, et al. Genetic markers associated with resistance to beta-lactam and quinolone antimicrobials in non-typhoidal Salmonella isolates from humans and animals in central Ethiopia. Antimicrob Resist Infect Control. 2017;6:13. doi:10.1186/s13756-017-0171-628105330
   PubMed Web of Science ®Google Scholar
• Feasey NA, Masesa C, Jassi C, et al. Three epidemics of invasive multidrug-resistant salmonella bloodstream infection in Blantyre, Malawi, 1998-2014. Clin Infect Dis. 2015;61(Suppl 4):S363–S371. doi:10.1093/cid/civ69126449953
   PubMed Web of Science ®Google Scholar
• Lunguya O, Lejon V, Phoba MF, et al. Antimicrobial resistance in invasive non-typhoid Salmonella from the Democratic Republic of the Congo: emergence of decreased fluoroquinolone susceptibility and extended-spectrum beta lactamases. PLoS Negl Trop Dis. 2013;7(3):e2103. doi:10.1371/journal.pntd.000210323516651
   PubMed Web of Science ®Google Scholar
• Kariuki S, Onsare RS. Epidemiology and genomics of invasive nontyphoidal salmonella infections in Kenya. Clin Infect Dis. 2015;61(Suppl 4):S317–S324. doi:10.1093/cid/civ71126449947
   PubMed Web of Science ®Google Scholar
• Ko WC, Yan JJ, Yu WL, et al. A new therapeutic challenge for old pathogens: community-acquired invasive infections caused by ceftriaxone- and ciprofloxacin-resistant Salmonella enterica serotype choleraesuis. Clin Infect Dis. 2005;40(2):315–318. doi:10.1086/42659315655754
   PubMed Web of Science ®Google Scholar
• Jones TF, Ingram LA, Cieslak PR, et al. Salmonellosis outcomes differ substantially by serotype. J Infect Dis. 2008;198(1):109–114. doi:10.1086/58882318462137
   PubMed Web of Science ®Google Scholar
• Luk-In S, Chatsuwan T, Pulsrikarn C, Bangtrakulnonth A, Rirerm U, Kulwichit W. High prevalence of ceftriaxone resistance among invasive Salmonella enterica serotype Choleraesuis isolates in Thailand: the emergence and increase of CTX-M-55 in ciprofloxacin-resistant S. Choleraesuis isolates. Int J Med Microbiol. 2018;308(4):447–453. doi:10.1016/j.ijmm.2018.03.00829605531
   PubMed Web of Science ®Google Scholar
• Galanis E, Lo Fo Wong DM, Patrick ME, et al. Web-based surveillance and global Salmonella distribution, 2000-2002. Emerg Infect Dis. 2006;12(3):381–388. doi:10.3201/eid1205.05085416704773
   PubMed Web of Science ®Google Scholar
• Kwambana-Adams B, Darboe S, Nabwera H, et al. Salmonella infections in The Gambia, 2005-2015. Clin Infect Dis. 2015;61(Suppl 4):S354–S362. doi:10.1093/cid/civ78126449952
   PubMed Web of Science ®Google Scholar
• Oneko M, Kariuki S, Muturi-Kioi V, et al. Emergence of community-acquired, multidrug-resistant invasive nontyphoidal salmonella disease in Rural Western Kenya, 2009-2013. Clin Infect Dis. 2015;61(Suppl 4):S310–S316. doi:10.1093/cid/civ67426449946
   PubMed Web of Science ®Google Scholar
• Helms M, Simonsen J, Molbak K. Quinolone resistance is associated with increased risk of invasive illness or death during infection with Salmonella serotype Typhimurium. J Infect Dis. 2004;190(9):1652–1654. doi:10.1086/42457015478071
   PubMed Web of Science ®Google Scholar
• Crump JA, Medalla FM, Joyce KW, et al. Antimicrobial resistance among invasive nontyphoidal Salmonella enterica isolates in the United States: National Antimicrobial Resistance Monitoring System, 1996 to 2007. Antimicrob Agents Chemother. 2011;55(3):1148–1154. doi:10.1128/AAC.01333-1021199924
   PubMed Web of Science ®Google Scholar
• Vlieghe ER, Phe T, De Smet B, et al. Azithromycin and ciprofloxacin resistance in Salmonella bloodstream infections in Cambodian adults. PLoS Negl Trop Dis. 2012;6(12):e1933. doi:10.1371/journal.pntd.000193323272255
   PubMed Web of Science ®Google Scholar
• Fenstemacher P. Practice guidelines for the management of infectious diarrhea. Clin Infect Dis. 2001;32(3):331–351. doi:10.1086/31851411170940
   PubMed Web of Science ®Google Scholar
• Helms M, Ethelberg S, Mølbak K, Group TDS. International Salmonella Typhimurium DT104 infections, 1992-2001. Emerg Infect Dis. 2005;11(6):859–867. doi:10.3201/eid1106.04101715963280
   PubMed Web of Science ®Google Scholar
• Ferrari R, Galiana A, Cremades R, et al. Plasmid-mediated quinolone resistance (PMQR) and mutations in the topoisomerase genes of Salmonella enterica strains from Brazil. Braz J Microbiol. 2013;44(2):651–656. doi:10.1590/S1517-8382201300020004624294265
   PubMed Web of Science ®Google Scholar
• Mather AE, Phuong TLT, Gao Y, et al. New variant of multidrug-resistant salmonella enterica serovar typhimurium associated with invasive disease in immunocompromised patients in Vietnam. MBio. 2018;9(5). doi:10.1128/mBio.01056-18
   Web of Science ®Google Scholar
• Redgrave LS, Sutton SB, Webber MA, Piddock LJ. Fluoroquinolone resistance: mechanisms, impact on bacteria, and role in evolutionary success. Trends Microbiol. 2014;22(8):438–445. doi:10.1016/j.tim.2014.04.00724842194
   PubMed Web of Science ®Google Scholar
• Baucheron S, Chaslus-Dancla E, Cloeckaert A, Chiu CH, Butaye P. High-level resistance to fluoroquinolones linked to mutations in gyrA, parC, and parE in Salmonella enterica serovar Schwarzengrund isolates from humans in Taiwan. Antimicrob Agents Chemother. 2005;49(2):862–863. doi:10.1128/AAC.49.2.862-863.200515673791
   PubMed Web of Science ®Google Scholar
• Robicsek A, Strahilevitz J, Jacoby GA, et al. Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase. Nat Med. 2006;12(1):83–88. doi:10.1038/nm134716369542
   PubMed Web of Science ®Google Scholar
• Antunes NT, Frase H, Toth M, Mobashery S, Vakulenko SB. Resistance to the third-generation cephalosporin ceftazidime by a deacylation-deficient mutant of the TEM beta-lactamase by the uncommon covalent-trapping mechanism. Biochemistry. 2011;50(29):6387–6395. doi:10.1021/bi200403e21696166
   PubMed Web of Science ®Google Scholar